BCT 2 1/2 (BROMOCRIPTINE 2.5 mg)

Pill imprint BCT 2 1/2 has been identified as Bromocriptine mesylate 2.5 mg.

Bromocriptine is used in the treatment of hyperprolactinemia; diabetes, type 2; parkinson's disease; acromegaly; tardive dyskinesia and belongs to the drug classes dopaminergic antiparkinsonism agents, prolactin inhibitors. There is no proven risk in humans during pregnancy. Bromocriptine 2.5 mg is not subject to the Controlled Substances Act.

See also related documents.

Imprint Search

Images for BCT 2 1/2

Bromocriptine mesylate 2.5 mg BCT 2 1/2  Front
Bromocriptine mesylate 2.5 mg BCT 2 1/2  Back
Bromocriptine mesylate
Imprint:
BCT 2 1/2
Strength:
2.5 mg
Color:
White
Size:
7.00 mm
Shape:
Round
Availability:
Prescription only
Drug Class:
Dopaminergic antiparkinsonism agents
Prolactin inhibitors
Pregnancy Category:
B - No proven risk in humans
CSA Schedule:
N - Not a controlled drug
Manufacturer:
Sandoz Pharmaceuticals Inc.
National Drug Code (NDC):
00781-5325
Inactive Ingredients:
silicon dioxide
corn starch
edetate disodium
lactose monohydrate
magnesium stearate
maleic acid
povidone

View Details Print Page

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2014 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide
(web1)